Lanreotide Depot
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lanreotide Depot, covering 2022-09-28 to 2022-09-28. Get the full timeline:
Most recent: Clinical Trial Update: Study of Pembrolizumab With Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors [Phase 1, Phase 2]